XXE5XBBMeasurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11
- Billable / Specific Code
- New for FY 2026
XXE5XBB is a billable ICD-10-PCS procedure code for Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Measurement involves determining the level of a physiological or physical function at a point in time.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | X | Physiological Systems |
| 3 | Operation | E | Measurement |
| 4 | BodyPart | 5 | Circulatory |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | B | Infection and Immune Response, Gene Expression Testing System |
| 7 | Qualifier | B | New Technology Group 11 |
Code History
- 8C02X6K — Collection of Blood from Indwelling Device in Circ Sys
Similar Procedure Codes
Questions About XXE5XBB
Is XXE5XBB a billable code?
Yes. XXE5XBB is a complete seven-character ICD-10-PCS code, specific enough to report Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XXE5XBB mean?
XXE5XBB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character E is the Operation (Measurement); the 4th character 5 is the BodyPart (Circulatory); the 5th character X is the Approach (External); the 6th character B is the Device/Substance/Technology (Infection and Immune Response, Gene Expression Testing System); the 7th character B is the Qualifier (New Technology Group 11).
